Concomitant interferon-α therapy and tumor necrosis factor α inhibition for rheumatoid arthritis and hepatitis C

被引:19
作者
Niewold, Timothy B. [1 ]
Gibofsky, Allan [1 ]
机构
[1] Hosp Special Surg, New York, NY 10021 USA
来源
ARTHRITIS AND RHEUMATISM | 2006年 / 54卷 / 07期
关键词
CHRONIC VIRAL-HEPATITIS; VIRUS-INFECTION; INDUCTION; SAFETY; TNF;
D O I
10.1002/art.21949
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:2335 / 2337
页数:3
相关论文
共 10 条
[1]   Safety of antitumour necrosis factor (anti-TNF) therapy in patients with chronic viral infections: hepatitis C, hepatitis B, and HIV infection [J].
Calabrese, LH ;
Zein, N ;
Vassilopoulos, D .
ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 :18-24
[2]   INDUCTION OF TUMOR-NECROSIS-FACTOR-ALPHA PRODUCTION BY HUMAN HEPATOCYTES IN CHRONIC VIRAL-HEPATITIS [J].
GONZALEZAMARO, R ;
GARCIAMONZON, C ;
GARCIABUEY, L ;
MORENOOTERO, R ;
ALONSO, JL ;
YAGUE, E ;
PIVEL, JP ;
LOPEZCABRERA, M ;
FERNANDEZRUIZ, E ;
SANCHEZMADRID, F .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 179 (03) :841-848
[3]  
Ioannou Y, 2000, ARTHRITIS RHEUM-US, V43, P1431, DOI 10.1002/1529-0131(200007)43:7<1431::AID-ANR3>3.0.CO
[4]  
2-E
[5]  
Mok MY, 2000, CLIN EXP RHEUMATOL, V18, P363
[6]   Activation of tumor necrosis factor-α system in chronic hepatitis C virus infection [J].
Nelson, DR ;
Lim, HL ;
Marousis, CG ;
Fang, JWS ;
Davis, GL ;
Shen, LP ;
Urdea, MS ;
Kolberg, JA ;
Lau, JYN .
DIGESTIVE DISEASES AND SCIENCES, 1997, 42 (12) :2487-2494
[7]   Cross-regulation of TNF and IFN-α in autoimmune diseases [J].
Palucka, AK ;
Blanck, JP ;
Bennett, L ;
Pascual, V ;
Banchereau, J .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (09) :3372-3377
[8]  
SHIOZAWA S, 1992, BRIT J RHEUMATOL, V31, P405
[9]  
Wong T, 2003, J RHEUMATOL, V30, P934
[10]   Etanercept as an adjuvant to interferon and ribavirin in treatment-naive patients with chronic hepatitis C virus infection: a phase 2 randomized, double-blind, placebo-controlled study [J].
Zein, NN .
JOURNAL OF HEPATOLOGY, 2005, 42 (03) :315-322